• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柳氮磺胺吡啶及其类似物在Caco-2细胞单层中的转运机制及结构-通透性关系

Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.

作者信息

Liang E, Proudfoot J, Yazdanian M

机构信息

Pharmaceutics Department, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT 06877, USA.

出版信息

Pharm Res. 2000 Oct;17(10):1168-74. doi: 10.1023/a:1026450326712.

DOI:10.1023/a:1026450326712
PMID:11145220
Abstract

PURPOSE

To investigate the mechanisms involved in transport of sulfasalazine in Caco-2 cells.

METHODS

Permeability coefficients of sulfasalazine and its analogs across Caco-2 cell monolayers were measured as a function of direction of transport, energy and concentration dependence, and in the presence of inhibitors of various cellular efflux pumps and transporters.

RESULTS

Permeability coefficients of sulfasalazine across Caco-2 cell monolayers were approximately 342-, 261-, and 176-fold higher from basolateral to apical direction (BL-->AP) than from apical to basolateral direction (AP-->BL) at 100, 200, and 500 microM, respectively. Carrier permeability coefficient, non-saturable membrane permeability coefficient, and Michaelis constant were estimated to be 1.4x10(-5) cm/s, 1.9x10(-8) cm/s, and 369 microM, respectively. The efflux of sulfasalazine was completely blocked at 4 degrees C and in the presence of an uncoupler of oxidative phosphorylation. Using cellular efflux inhibitors, the permeability of sulfasalazine was shown to depend on multidrug resistance-associated protein and anion sensitive transport mechanisms. Structure-permeability studies showed that the affinity of sulfasalazine for the cellular efflux pumps and transporters in Caco-2 cells depended strongly on the carboxylic acid functional group.

CONCLUSIONS

The permeability of sulfasalazine across Caco-2 cell monolayer is very low due to its strong interaction with multiple cellular efflux pumps and transporters. This may partially explain its low absorption in vivo.

摘要

目的

研究柳氮磺胺吡啶在Caco-2细胞中的转运机制。

方法

测量柳氮磺胺吡啶及其类似物跨Caco-2细胞单层的渗透系数,作为转运方向、能量和浓度依赖性的函数,并在存在各种细胞外排泵和转运体抑制剂的情况下进行测量。

结果

在100、200和500微摩尔浓度下,柳氮磺胺吡啶跨Caco-2细胞单层从基底外侧到顶端方向(BL→AP)的渗透系数分别比从顶端到基底外侧方向(AP→BL)高约342倍、261倍和176倍。载体渗透系数、非饱和膜渗透系数和米氏常数估计分别为1.4×10⁻⁵厘米/秒、1.9×10⁻⁸厘米/秒和369微摩尔。柳氮磺胺吡啶的外排在4℃和存在氧化磷酸化解偶联剂的情况下完全被阻断。使用细胞外排抑制剂,柳氮磺胺吡啶的渗透性显示取决于多药耐药相关蛋白和阴离子敏感转运机制。结构-渗透性研究表明,柳氮磺胺吡啶对Caco-2细胞中细胞外排泵和转运体的亲和力强烈依赖于羧酸官能团。

结论

柳氮磺胺吡啶跨Caco-2细胞单层的渗透性非常低,这是由于它与多种细胞外排泵和转运体的强烈相互作用。这可能部分解释了其在体内的低吸收。

相似文献

1
Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.柳氮磺胺吡啶及其类似物在Caco-2细胞单层中的转运机制及结构-通透性关系
Pharm Res. 2000 Oct;17(10):1168-74. doi: 10.1023/a:1026450326712.
2
Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.由多药耐药相关蛋白2(MRP2)和乳腺癌耐药蛋白(BCRP)介导的小肠外排作用将柳氮磺胺吡啶的肠道通透性从高转变为低,从而实现其结肠靶向性。
Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7. doi: 10.1152/ajpgi.00102.2009. Epub 2009 Jun 18.
3
MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.MRP2 介导的药物相互作用:吲哚美辛增加了磺胺吡啶在小肠中的吸收,可能会降低其在结肠的靶向性。
Int J Pharm. 2010 Feb 15;386(1-2):216-20. doi: 10.1016/j.ijpharm.2009.11.021. Epub 2009 Nov 26.
4
The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.H2受体拮抗剂尼扎替丁是一种P-糖蛋白底物:其肠上皮细胞外排转运的特征
AAPS J. 2009 Jun;11(2):205-13. doi: 10.1208/s12248-009-9092-5. Epub 2009 Mar 25.
5
Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.阿托伐他汀在Caco-2细胞模型中的转运:P-糖蛋白和质子-单羧酸共转运体的作用
Pharm Res. 2000 Feb;17(2):209-15. doi: 10.1023/a:1007525616017.
6
Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.P-糖蛋白在丹参主要活性成分丹参酮IIA肠道吸收中的作用。
Curr Drug Metab. 2007 May;8(4):325-40. doi: 10.2174/138920007780655450.
7
Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.表达高水平多药耐药蛋白外排转运体的Caco-2亚克隆的分离与鉴定
Pharm Res. 2003 Feb;20(2):161-8. doi: 10.1023/a:1022359300826.
8
Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).利用过表达P-糖蛋白(Pgp)、多药耐药相关蛋白(MRP1)和小管多特异性有机阴离子转运体(cMOAT)的Madin-Darby犬肾(MDCK)细胞,描绘分泌性转运体在依托泊苷外排中的作用。
Drug Metab Dispos. 2002 Apr;30(4):457-63. doi: 10.1124/dmd.30.4.457.
9
An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.黄酮类化合物介导2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)通过Caco-2单层细胞转运的体外和计算机模拟研究。
Toxicol Appl Pharmacol. 2006 Dec 1;217(2):204-15. doi: 10.1016/j.taap.2006.08.005. Epub 2006 Aug 10.
10
Characterization of efflux transporters involved in distribution and disposition of apixaban.鉴定与阿哌沙班分布和处置相关的外排转运体。
Drug Metab Dispos. 2013 Apr;41(4):827-35. doi: 10.1124/dmd.112.050260. Epub 2013 Feb 4.

引用本文的文献

1
Mesalazine-PAMAM Nanoparticles for Transporter-Independent Intracellular Drug Delivery: Cellular Uptake and Anti-Inflammatory Activity.载氨磷酰基聚酰胺纳米粒用于非载体依赖型细胞内药物递送:细胞摄取和抗炎活性。
Int J Nanomedicine. 2023 Apr 24;18:2109-2126. doi: 10.2147/IJN.S390763. eCollection 2023.
2
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.治疗炎症性肠病的临床药代动力学和药效学考虑因素。
Clin Pharmacokinet. 2018 Sep;57(9):1075-1106. doi: 10.1007/s40262-018-0639-4.
3
A novel biosensor based on intestinal 3D organoids for detecting the function of BCRP.

本文引用的文献

1
Structural characterization of substrates for the anion exchange transporter in Caco-2 cells.
J Pharm Sci. 1999 Nov;88(11):1217-21. doi: 10.1021/js9900093.
2
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.有机阳离子转运体2(OCTN2)介导的Na(+)依赖性肉碱转运:其药理学和毒理学意义
J Pharmacol Exp Ther. 1999 Nov;291(2):778-84.
3
Transport characteristics of diphenhydramine in human intestinal epithelial Caco-2 cells: contribution of pH-dependent transport system.苯海拉明在人肠上皮Caco-2细胞中的转运特性:pH依赖性转运系统的作用
一种基于肠道三维类器官的新型生物传感器,用于检测乳腺癌耐药蛋白(BCRP)的功能。
Drug Deliv. 2017 Nov;24(1):1453-1459. doi: 10.1080/10717544.2017.1381199.
4
Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.灌注微血管平台中阿霉素转运的实时成像与定量分析
Integr Biol (Camb). 2016 Sep 12;8(9):976-84. doi: 10.1039/c6ib00082g. Epub 2016 Aug 15.
5
Prediction of the permeability of neutral drugs inferred from their solvation properties.基于中性药物溶剂化性质推断其渗透性的预测
Bioinformatics. 2016 Apr 15;32(8):1163-9. doi: 10.1093/bioinformatics/btv725. Epub 2015 Dec 10.
6
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.综述文章:用于治疗炎症性肠病的药物的药代动力学和药效学
Eur J Clin Pharmacol. 2015 Jul;71(7):773-99. doi: 10.1007/s00228-015-1862-7. Epub 2015 May 27.
7
Study on the mechanism of intestinal absorption of epimedins a, B and C in the Caco-2 cell model.研究淫羊藿甲素、淫羊藿乙素和淫羊藿丙素在 Caco-2 细胞模型中的肠吸收机制。
Molecules. 2014 Jan 7;19(1):686-98. doi: 10.3390/molecules19010686.
8
Computational models to assign biopharmaceutics drug disposition classification from molecular structure.基于分子结构进行生物药剂学药物处置分类的计算模型。
Pharm Res. 2007 Dec;24(12):2249-62. doi: 10.1007/s11095-007-9435-9. Epub 2007 Sep 11.
9
Predicting effect of food on extent of drug absorption based on physicochemical properties.基于物理化学性质预测食物对药物吸收程度的影响。
Pharm Res. 2007 Jun;24(6):1118-30. doi: 10.1007/s11095-007-9236-1. Epub 2007 Mar 24.
10
Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine.芍药苷口服生物利用度差的机制:肠道处置作用及与青藤碱的相互作用
Pharm Res. 2006 Dec;23(12):2768-80. doi: 10.1007/s11095-006-9100-8. Epub 2006 Oct 25.
J Pharmacol Exp Ther. 1999 Jul;290(1):388-92.
4
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.大鼠脑中一种新型多特异性有机阴离子转运体的分子克隆与特性分析
J Biol Chem. 1999 May 7;274(19):13675-80. doi: 10.1074/jbc.274.19.13675.
5
Cloning and functional expression of a mouse liver organic cation transporter.小鼠肝脏有机阳离子转运体的克隆与功能表达
Hepatology. 1999 May;29(5):1556-62. doi: 10.1002/hep.510290530.
6
Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds.结构多样的小分子化合物的分配与Caco-2细胞通透性的相关性
Pharm Res. 1998 Sep;15(9):1490-4. doi: 10.1023/a:1011930411574.
7
Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.大鼠和人肠道以及Caco-2细胞中药物外排的区域肠道动力学特征。
Pharm Res. 1998 Aug;15(8):1160-7. doi: 10.1023/a:1011971303880.
8
Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.采用过表达P-糖蛋白细胞的放射性配体结合试验:检测药物对分泌性肠道多药转运体的亲和力
Pharm Res. 1998 Jul;15(7):1001-6. doi: 10.1023/a:1011965707998.
9
Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers.拟肽的转运特性。吡咯烷酮生物电子等排体对跨Caco-2细胞单层转运的影响。
Pharm Res. 1998 May;15(5):719-25. doi: 10.1023/a:1011966918959.
10
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.药物转运体P-糖蛋白限制了HIV-1蛋白酶抑制剂的口服吸收和进入脑部。
J Clin Invest. 1998 Jan 15;101(2):289-94. doi: 10.1172/JCI1269.